Esperion Therapeutics, Inc. ( NASDAQ:ESPR – Get Rating ) CEO Sheldon L. Koenig sold 5,441 shares of the business's stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $5.06, for a total value of $27,531.46. Following the sale, the chief executive officer now owns 194,815 shares in the company, valued at $985,763.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink . Esperion Therapeutics Stock Up 0.

https://www.dailypolitical.com/2023/03/09/insider-selling-esperion-therapeutics-inc-nasdaqespr-ceo-sells-5441-shares-of-stock.html

#dailypolitical